LNTH Q2 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$86M-3.7% YoY

Gross Profit

$44M51.2% margin

Operating Income

$16M18.6% margin

Net Income

$10M11.4% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$402M

Total Liabilities

$357M

Stockholders' Equity

$45M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$89M	-3.7%
Gross Profit	$44M	$46M	-4.6%
Operating Income	$16M	$18M	-11.0%
Net Income	$10M	$14M	-28.3%

Revenue Segments

Product Revenue, Net

$85M99%

License and Royalty Revenues

$569,0001%